Subham Preetam is a professional biotechnologist who collaborates with a creative bio-robotics researcher. His area of expertise lies in early-stage research in biomedical robotics engineering, with a particular interest in quantum engineering for the manufacturing of bio-hybrid robots. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals.

With extensive cross-disciplinary training and experience in translational research, Mr. Preetam is currently focused on various research topics, including micro-robotics, soft bio-hybrid robots, and quantum nanorobot fabrication for removing heavy metals from ocean water. His research aims to improve the life expectancy of sea animals and humans.

Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer patients in South Korea and Sweden. Additionally, he collaborates with researchers from India, Taiwan, Israel, Saudi Arabia, the US, China, Denmark, Singapore, Spain, Portugal, and the United Kingdom on various collaborative projects.

Our lab uses genetically modified mouse models and a combination of cell biology, molecular biology, and biochemistry techniques to study the role of altered mitochondrial dysfunction and metabolism in human diseases. A primary analytical tool of the group is metabolomics, which enables the parallel quantification of hundreds of small molecule metabolites. The team also uses computational approaches to integrate datasets from multi-dimensional analyses, including metabolomics, proteomics, and transcriptomics, with the aim to model aging-related disorders and to generate mechanistic hypotheses that will be cross validated experimentally.